Surmodics (SRDX) Competitors $30.61 -0.60 (-1.92%) Closing price 04:00 PM EasternExtended Trading$30.60 0.00 (-0.02%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SRDX vs. ATEC, ATRC, IART, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Surmodics vs. Its Competitors Alphatec AtriCure Integra LifeSciences Orthofix Medical AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Alphatec (NASDAQ:ATEC) and Surmodics (NASDAQ:SRDX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends. Which has higher valuation & earnings, ATEC or SRDX? Surmodics has lower revenue, but higher earnings than Alphatec. Surmodics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlphatec$611.56M2.54-$162.12M-$1.15-9.24Surmodics$126.08M3.47-$11.54M-$1.39-22.02 Which has more volatility and risk, ATEC or SRDX? Alphatec has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Do analysts recommend ATEC or SRDX? Alphatec presently has a consensus target price of $18.13, suggesting a potential upside of 70.51%. Surmodics has a consensus target price of $43.00, suggesting a potential upside of 40.48%. Given Alphatec's stronger consensus rating and higher probable upside, research analysts clearly believe Alphatec is more favorable than Surmodics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alphatec 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Surmodics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is ATEC or SRDX more profitable? Surmodics has a net margin of -16.34% compared to Alphatec's net margin of -25.77%. Surmodics' return on equity of -7.10% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets Alphatec-25.77% -1,657.19% -21.53% Surmodics -16.34%-7.10%-4.77% Does the media favor ATEC or SRDX? In the previous week, Alphatec had 11 more articles in the media than Surmodics. MarketBeat recorded 11 mentions for Alphatec and 0 mentions for Surmodics. Surmodics' average media sentiment score of 1.89 beat Alphatec's score of 1.12 indicating that Surmodics is being referred to more favorably in the news media. Company Overall Sentiment Alphatec Positive Surmodics Very Positive Do insiders & institutionals have more ownership in ATEC or SRDX? 66.4% of Alphatec shares are held by institutional investors. Comparatively, 96.6% of Surmodics shares are held by institutional investors. 20.9% of Alphatec shares are held by company insiders. Comparatively, 8.9% of Surmodics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryAlphatec and Surmodics tied by winning 8 of the 16 factors compared between the two stocks. Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRDX vs. The Competition Export to ExcelMetricSurmodicsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$446.28M$10.32B$5.57B$9.35BDividend YieldN/A2.05%3.80%4.06%P/E Ratio-22.0210.9619.8919.49Price / Sales3.4729.26441.5099.93Price / Cash100.8822.2635.8457.94Price / Book3.673.618.265.67Net Income-$11.54M$233.40M$3.24B$257.80M7 Day Performance-1.32%-3.35%0.50%1.07%1 Month Performance5.37%4.19%7.99%11.31%1 Year Performance-27.03%-17.80%28.68%17.01% Surmodics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRDXSurmodics4.5341 of 5 stars$30.61-1.9%$43.00+40.5%-25.9%$446.28M$126.08M-22.02450Positive NewsATECAlphatec4.2172 of 5 stars$10.91-0.7%$17.89+64.0%-10.4%$1.59B$642.27M-9.49700Positive NewsATRCAtriCure3.1139 of 5 stars$31.30+1.9%$50.67+61.9%+20.1%$1.55B$480.08M-38.641,300IARTIntegra LifeSciences4.1351 of 5 stars$12.21-3.0%$18.63+52.5%-61.9%$948.84M$1.61B-32.134,396OFIXOrthofix Medical2.7275 of 5 stars$10.98-0.6%$21.50+95.8%-33.7%$430.20M$799.49M-2.981,616ANGOAngioDynamics4.0721 of 5 stars$9.63+3.3%$14.00+45.4%+14.5%$391.05M$283.32M-9.53760Trending NewsEarnings ReportAnalyst ForecastHigh Trading VolumeARAYAccuray2.576 of 5 stars$1.36flatN/A-34.8%$140.10M$465.25M0.001,040Positive NewsRMTIRockwell Medical3.9007 of 5 stars$1.11-1.8%$4.00+260.4%-48.6%$37.93M$97.73M0.00300News CoverageRSLSReShape Lifesciences0.6105 of 5 stars$2.39+0.4%N/A-99.2%$5.71M$8.01M-0.0150Positive NewsABTAbbott Laboratories4.9888 of 5 stars$132.05+0.0%$143.11+8.4%+28.3%$229.74B$42.34B17.13114,000Trending NewsEarnings ReportAnalyst ForecastGap DownISRGIntuitive Surgical4.6558 of 5 stars$516.44+0.9%$592.86+14.8%+17.0%$185.10B$8.35B75.7215,638Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Alphatec Competitors AtriCure Competitors Integra LifeSciences Competitors Orthofix Medical Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRDX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRDX Stock Alerts